Clearmind Medicine Inc (CMND)
1.13
-0.01
(-0.88%)
USD |
NASDAQ |
May 31, 16:00
1.12
-0.01
(-0.88%)
After-Hours: 20:00
Clearmind Medicine Free Cash Flow (Quarterly): -1.462M for Jan. 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | -1.462M |
October 31, 2023 | -0.3709M |
July 31, 2023 | -1.130M |
April 30, 2023 | 0.0483M |
January 31, 2023 | -3.103M |
October 31, 2022 | -0.0223M |
July 31, 2022 | -0.1984M |
April 30, 2022 | -1.116M |
January 31, 2022 | -1.400M |
October 31, 2021 | -0.9449M |
July 31, 2021 | -0.3301M |
April 30, 2021 | -0.4651M |
January 31, 2021 | -0.0726M |
Date | Value |
---|---|
October 31, 2020 | -0.0583M |
July 31, 2020 | -0.0636M |
April 30, 2020 | -0.0849M |
January 31, 2020 | 0.0008M |
October 31, 2019 | -0.0094M |
July 31, 2019 | -0.0227M |
April 30, 2019 | -0.0029M |
January 31, 2019 | -0.0205M |
October 31, 2018 | -0.0825M |
July 31, 2018 | -0.0594M |
April 30, 2018 | -0.0133M |
January 31, 2018 | -0.0252M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-3.103M
Minimum
Jan 2023
0.0483M
Maximum
Apr 2023
-0.5687M
Average
-0.1984M
Median
Jul 2022
Free Cash Flow (Quarterly) Benchmarks
ImmunoPrecise Antibodies Ltd | -0.3767M |
Acasti Pharma Inc | -1.892M |
Aurinia Pharmaceuticals Inc | 14.25M |
Edesa Biotech Inc | -1.660M |
Lexaria Bioscience Corp | -0.6766M |